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Endoderm-beta is a multifunctional growth factor with roles in normal development and
disease pathogenesis. One such role is in inhibition of lung branching morphogenesis, although the precise
mechanism remains unknown. In an explant model, all three TGFβ isoforms inhibited FGF10-induced
morphogenesis of mesenchyme-free embryonic lung endoderm. Inhibition of budding by TGFβ was partially
abrogated in endodermal explants from Smad3−/− or conditional endodermal-speciﬁc Smad4Δ/Δ embryonic
lungs. Endodermal explants from conditional TGFβ receptor II knockout lungswere entirely refractive toTGFβ-
induced inhibition. Inhibition of morphogenesis was associated with dedifferentiation of endodermal cells as
documented by a decrease in key transcriptional factor, NKX2.1 protein, and its downstream target, surfactant
protein C (SpC). TGFβ reduced the proliferation of wild-type endodermal cells within the explants as assessed
by BrdU labeling. Gene expression analysis showed increased levels of mRNA for Pten, a key regulator of cell
proliferation. Conditional, endodermal-speciﬁc deletion of Pten overcame TGFβ's inhibitory effect on cell
proliferation, but did not restoremorphogenesis. Thus, themechanisms bywhich TGFβ inhibits FGF10-induced
lung endodermal morphogenesis may entail both inhibition of cell proliferation, through increased Pten, as
well as inhibition or interference with morphogenetic mediators such as Nkx2.1. Both of the latter are
dependent on signaling through TβRII.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe mammalian lung is a complex structure that is derived by
branching morphogenesis from at least two separate tissues; the
foregut endoderm and the splanchnic mesenchyme. Whereas some
molecules promote endodermal branching, others are known to be
inhibitory. On the positive side, members of the ﬁbroblast growth
factor (FGFs) and in particular FGF10 that originate from the mesen-
chyme are potent chemotactic signaling molecules. FGF10 acts on the
pulmonary endoderm to elicit budding and branching morphogenesis
(De Moerlooze et al., 2000). Disruption of Fgf10 blocks pulmonary
endodermal morphogenesis resulting in a complete lack of lung pa-
renchyma distal to the trachea (Min et al., 1998; Sekine et al., 1999). In
vitro, FGF10 alone is both necessary and sufﬁcient for morphogenesis
in mesenchyme-free endodermal explants (Bellusci et al., 1997).
In contrast to FGFs, the overall role of TGFβ is thought to be inhi-
bitory. TGFβ is a key regulator of cell migration, differentiation,, 1801 E. Marengo Street, Room
.
l rights reserved.proliferation and apoptosis (Roberts, 1998). In the lung, two aspects of
TGFβ function have been addressed. First, pathological effects of TGFβ
and in particular ﬁbrosis have been extensively studied in various lung
injury models including bleomycin and hyperoxia (Westergren-
Thorsson et al., 1993; Santana et al., 1995; Coker et al., 1997). Physio-
logical role(s) of endogenous TGFβ in lungdevelopment and regulation
of gene expression have also been addressed via deletion of speciﬁc
genes encoding the three TGFβ isoforms (for a review please see Shi
and Massagué, 2003).
The binding of TGFβ to its receptors, TβRII and TβRI initiates a
cascade of phosphorylation events that eventually result in nuclear
translocation of Smad2 and Smad3. Smads interact with several
transcriptional activators or repressors, and modify gene expression
(Eickelberg, 2001; Shi andMassagué, 2003; tenDijke et al., 2004). Gene
knockout studies suggest that the function of each Smad is distinct.
Whereas Smad3−/− animals are viable (Datto et al., 1999), Smad2−/− dies
during early embryogenesis (Heyer et al., 1999). Lung morphogenesis
occurs normally in the Smad3−/− mice, indicating that the role of
endogenous TGFβ in lung development is not dependent on SMAD3
activity (Datto et al., 1999). In contrast, pathological impact of TGFβ on
lung morphogenesis may be distinct (Zhou et al., 1996; Serra et al.,
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ary ﬁbrosis is attenuated indicating at least a partial role for SMAD3
(Zhao et al., 2002). Also, TGFβ inhibition of cell differentiation and gene
expression appears to be in large part due to the activity of SMAD3
(Alliston et al., 2001; Liu et al., 2001; Li et al., 2005). Whether the
impact of TGFβ on lungmorphogenesis is dependent on the activity of
SMADs remains unknown.
A central pathway of growth factor signaling occurs through the
activity of phosphotidylinositol-3-kinase, or PI3K. Pten a cancer sup-
pressor gene localized to 10q23 encodes a protein tyrosine phospha-
tase that counters the activity of PI3K, therefore affecting cell pro-
liferation, size, migration and death (Andrés-Pons et al., 2007; Stiles
et al., 2004). Absence of Pten results in over-activation of several key
signalingmolecules includingAKT/PKB (reviewed in Stiles et al., 2004).
Thus, the PTEN/AKT pathway is amajor participant in regulation of cell
cycle progression and cell differentiation. In transformed cell lines,
Pten mRNA is rapidly reduced in response to TGFβ (Chow et al.,
2007). Pten is also expressed at high levels in embryonic stem cells
(Takahashi et al., 2005). Loss of Pten in the intestinal stem cells initiates
polyposis, a condition characterized by precancerous neoplastic
increase in the number of crypts, which contain intestinal stem cells
(He et al., 2007). Therefore, Pten governs the proliferation rate and
number of intestinal stem cells and its loss results in an excess of such
cells. The in vivo relationship between TGFβ signaling, Pten and cell
proliferation remains unknown. However, an indirect link between
diminished Pten and TGFβ has been noted in human idiopathic
pulmonary ﬁbrosis (Waite and Eng, 2003).
In the current study we assessed the direct impact of TGFβ on
isolated mesenchyme-free embryonic lung endodermal explants. The
results demonstrate that all three isoforms of TGFβ inhibit lung
endodermal morphogenesis. Inhibitory impact of TGFβ is only partly
dependent on Smads, but requires functional TβRII activity. TGFβ-
induced inhibition of endodermal morphogenesis is associated with
inhibition of cell proliferation, which is in large part due to increased
expression of Pten.
Materials and methods
Mouse lines
Smad3+/−micewere generated as previously described andwere a gift fromDr. Datto
(Datto et al.,1999). Generation of TGFβReceptor II, TβRII ﬂox/ﬂoxmice has beenpreviously
described (Chytil et al., 2002). These mice were a gift from Dr. Chai (USC Dental School).
Generation of Nkx2.1-cremice has been reported (Xu et al., 2008). Bmp4LacZ/+ mice were
a gift from Dr. Brigid Hogan (Duke University, Durham, NC). Smad4ﬂox/ﬂox mice were
kindly provided by Dr. Deng (Yang et al., 2002). Ptenﬂox/ﬂox mice (Freeman et al., 2006)
were purchased from Jackson Labs (Maine, USA). All of themice are C57BL/6 background.
The DNA sequences of the Primers were obtained from the respective publications for
each of the strains of mice listed above.
Lung culture and lung endodermal explant culture
Whole embryonic lungs were dissected at gestational stage E11.5. In each Grobstein
Falcon dish, two to three lungs were placed on ﬁlters (Millipore, Bedford, MA) that were
placed on top of a stainless steel grid. The ﬁlterswere in close contact with BGJb (GIBCO)
growth medium supplemented with penicillin (100 U/ml) and streptomycin (100 μg/
ml), with 10 or 50 ng/ml recombinant human TGFβ1 peptide (R&D systems) or same
amount of Bovine Serum Albumin (BSA) as control. Heparin beads (Sigma) were incu-
batedwith recombinant humanTGFβ1 (10 μl of a 50 ng/μl solution; R&D Systems,MN) or
in BSA (control) at 37 °C for 2 h, grafted onto lung explants and cultured for 48 h or 96 h.
The lungswere incubated under optimal humidity in 95% air/5% CO2. At indicated times,
the lung explantswere either homogenized inTrizol (GIBCO) for RNA isolation orﬁxed in
4% Paraformaldehyde (PFA).
For mesenchyme-free endodremal lung explant culture, distal lung tips were
isolated as previously described (Bellusci et al., 1997). Brieﬂy, lungs from mutant or
control embryos were dissected at E12.5 and treated with Dispase (50 U/ml, BD
Biosciences) at 4 °C for 20 min. Epithelial buds of distal lung tips were then isolated by
removing mesenchyme with tungsten needles and embedded into growth factor-
reduced Matrigel (Fisher Scientiﬁc), diluted 1:1 in culture medium (50% DMEM: 50%
Ham's F12, 0.05 U/ml penicillin, 0.05 mg/ml streptomycin). After polymerization of the
Matrigel at 37 °C, explants were covered with culture mediumwith or without FGF and
TGFβs and cultured at 37 °C at 5% CO2 for various lengths of time as indicated.Proliferation assay
Subsequent to culturing, endodermal explants were treated with bromodeoxyur-
dine (BrdU) reagent at 1 μl per 400 μl medium for 3 h. The explants were ﬁxed,
dehydrated and parafﬁn embedded. The sections were then re-hydrated and labeled by
BrdU staining kit (Zymed Laboratories Inc.) and Hematoxylin/Eosin staining. The
sections were then photographed. The BrdU positive cells as well as the total number of
cells (Hematoxylin/Eosin positive cells) in the explants per section were counted
manually using photomicrograph of tissue taken at 40∼ on a Zeiss Microscope. The
percent of labeled cells was calculated. To compare the proliferation in FGF10 or FGF10+
TGFβ1 treated endodermal explants, 678 cells/5 sections from FGF10 treatment and 399
cells/4 sections from FGF10+TGFβ1 treatment were analyzed. To compare the
proliferation in wild-type and PtenΔ/Δ endodermal explants after FGF10 or FGF10+
TGFβ1 treatments, 2651 cells/7 sections and 734 cells/7 sections from wild-type
explants and 1343 cells/8 sections and 1035 cells/8 sections from PtenΔ/Δ explants were
analyzed.
Cell death analysis
The cultured endodermal explants were ﬁxed, dehydrated and embedded in
parafﬁn and 5-μm sections were prepared. The “In Situ Cell Death Detection Kit,
Fluoresein” kit (Roche Allied Science) was used for detection and quantiﬁcation of cell
apoptosis at single cell level, based on labeling of DNA strand breaks (TUNEL
technology). The sizes of labeled areas and whole sections were calculated for the
percentage of cell death. 5 sections from each treatment were analyzed.
Immunohistochemistry
5 μm tissue sections were prepared. Subsequent to deparafﬁnization, the sections
were hydrated, heated in 10 mM citrate buffer (pH 6.0) and treated with 10% H2O2 in
methanol for 20 min and blocked with 10% of nonimmune serum. Sections were then
incubated with primary antibodies at 4 °C overnight. Biotinylated secondary antibody
and streptavidin-peroxidase conjugate (Vector Laboratories, Inc.) were used to detect
the bound antibodies. The sections were developed with diaminobenzidine. NKX2.1
primary antibody was purchased from R&D Systems.
RNA extraction and RT-PCR
Total RNAwas isolated from lungs or endodermal explants using Trizol (GIBCO). The
cDNAwas synthesized from1 μg total RNAby following the protocol of the SuperScript™
First-Strand Synthesis Kit (Invitrogen, Carlsbad, USA). Primer sets for following genes
were used for RT-PCR.
β-actin: 5′-GTCGTACCACAGGCATTGTGATGG-3′ and 5′-GCAATGCCTGGGTACATGG
TGG-3′; Sp-C: 5′-GGACATGAGTAGCAAAGAGG-3′ and 5′-TAGAGTGGTAGCTCTCCAC;
Nkx2.1: 5′-AACCTGGGCAACATGAGCGAGCTG-3′ and 5′-ATCTTGACCTGCGTGGGTGT
CAGG-3′; CK19: 5′-GCAGAACCGGAAGGATGCT-3′ and 5′-TCCGTTTCTGCCAGTGTGT C
-3′; N-myc: 5′-CAATGGTGCTTAAGTTCCAG-3′ and 5′-AGTGCTCATAAGGTGCAGCA -3′;
Shh: 5′-GTGGCCGAGAAGACCCTAG-3′ and 5′-AGACGTGGTGATGTCCACTG-3′; Sox9: 5′-
TGAAGAAGGAGAGCGAGGAAGATAA-3′ and 5′-GGTGGCAAGTATTGGTCAA ACTCA-3′;
Tff3: 5′-ATGGAGACCAGAGCCCTCTG-3′ and 5′-CAAAATGTGCATTCTGTC TCC-3′; Bmp4:
5′-ACAATGTGACACGGTGGGAAAC-3′ and 5′-TGTGGGTGATGCTTGG GACTAC-3′; Pten:
5′-CCACAAACAGAACAAGATGCTC-3′ and 5′-CCATTTTCCACTTTT TCTGAGG-3′; Primer
sets for following genes were used for Real-time RT-PCR: Pten: 5′-CCACAAACAGAA-
CAACAAGATGCTC-3′ and 5′-TTCCATTTTCCACTTTTTC TGAG-3′; Egr1: 5′-GACGAGT-
TATCCCAGCCAAA-3′ and 5′-GGCAGAGGAAGACGA TGAAG-3′. Real-time RT-PCR was
performed by a LightCycler System (Roche).
Results
TGFβ1 does not inhibit branching morphogenesis in embryonic lung
explant culture
As a ﬁrst step toward analyzing the impact of TGFβ on lung mo-
rphogenesis, we attempted to recapitulate the previously reported
ﬁndings, using embryonic whole lung explants (Zhao et al., 1999a;
Serra et al., 1994). E11.5 embryonic mouse lungs were excised from
mouse embryos and cultured in a serum-free medium (Minoo et al.,
1995) in presence or absence of 10 or 50 ng/ml TGFβ1 ligand (Fig. 1,
Panels A to C). At 48 and 96 h, cultures were terminated and the
individual lung explants removed and analyzed for overall branching
morphogenesis and gene expression. Contrary to previous ﬁndings
(Serra et al., 1994; Zhao et al., 1999a), exposure to TGFβ for 48 h had
little if any discernible impact on branching morphogenesis of E11.5
embryonic lungs. The measured average number of terminal branches
in two set of lungs, one consisting of 8 and the other 10 embryonic
lungs treated respectively with 10 ng/ml or 50 ng/ml of TGFβ1 was 13
Fig. 1. TGFβ does not inhibit branching morphogenesis of lung explants. E11.5 mouse embryonic lungs (Panel A) underwent morphogenesis after 96 h in explant culture in deﬁned
serum-free medium (Panel B). TGFβ had little, if any impact on branching morphogenesis (Panel C). No differences in branching were observed after 48 h between SpC-Gfp lungs
embedded with TGFβ- or BSA-soaked beads (Panels D–F). Panels E and F are high magniﬁcation of Panel D. Arrows show the location of the beads. Branching morphogenesis was
quantiﬁed by determination of the number of terminal branch points (Panel G). Real-time PCR analysis of Plasminogen Activator Inhibitor 1 (PAI-1) in presence or absence of 50 ng/ml
TGFβ ligand (Panel H).
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control group without TGFβ1 treatment showed an average of 14
branches (data not show). Similarly, exposure of E11.5 embryonic lungs
for 4 days to TGFβ1 had little effect on branching morphogenesis. The
average number of terminal branches in the 3 lungs treated for 4 days
was measured to be 19. An exactly identical average number of
terminal branch points was measured for the lungs in the control
group (Fig. 1, Panel G).
To make certain that the TGFβ ligand added to the cultured lungs
was functional wemeasuredmRNA for Plasminogen Activator Inhibitor
1, PAI-1, a well-established downstream target of TGFβ (Liu et al., 1997).
Competitive real-time PCR quantiﬁcation revealed that PAI-1 mRNA
was increased by nearly 10 fold in lungs treated with TGFβ, compared
with untreated controls (Fig. 1, Panel H). The validity of the explant
culture results was further tested by implantation of TGFβ-soaked
(Bovine Serum Albumin as control) heparin beads in lung explants. To
reﬁne the visualization of the endodermal branches we used E11.5
embryonic lungs from transgenic SpC-Gfp (Green Fluorescent Protein)
mice. As before, no signiﬁcant differences in branching morphogenesis
were detectable between the surrounding lung tissue containing TGFβ1
beads (Fig. 1, Panel F) versus BSA beads (Fig. 1, Panel E).
TGFβ inhibits FGF10-induced morphogenesis of mesenchyme-free lung
endoderm in explant culture
Because contrary towhat has been reported (Serra et al.,1994; Zhao
et al., 1999a) TGFβ did not inhibit branching morphogenesis in wholeembryonic lung explants, we examined the response of mesenchyme-
free endodermto all three isoforms of TGFβ. Mesenchyme-free nascent
endodremal tissue can be isolated fromwhole mouse embryos on day
12.5 of gestation (E12.5) and explanted in Matrigel for various studies
(Bellusci et al., 1997). This model offers a number of advantages over
the whole lung explant. For example, as the endoderm in whole lung
explants is surrounded by mesenchyme, molecules under investiga-
tion (e.g. growth factors) may never penetrate through this layer to
reach the endodermal cells to elicit their physiologic effects. In
addition, this model allows for direct visualization of the behavior of
the endoderm in response to various experimental factors. Culturing of
endodermal explants requires the presence of FGF10, which is ne-
cessary and sufﬁcient to direct morphogenesis (Bellusci et al., 1997b).
In the absence of exogenous FGF10, the endodermal explants fail to
proliferate and rapidly undergo necrosis. Thus, in the following studies
what is precisely examined is the interaction between FGF10 and TGFβ
isoforms in isolated lung endodermal explants. Overall, a total of 44
mesenchyme-free endodermal explants were cultured in Matrigel in
groups of 4 inpresence or absence of 10 ng/ml of each of the three TGFβ
ligands. All explant cultures contained 400 ng/ml of FGF10 ligand for
survival and induction of morphogenesis as described previously
(Bellusci et al., 1997). Fig. 2 shows the results of these studies at times 0
and 48 h. As expected, FGF10 had a robust impact on induction of
morphogenesis in E12.5 wild-type lung endoderm (Fig. 2, compare
Panels A and E). Without exception, presence of any of the three TGFβ
isoforms at 10 ng/ml strongly inhibited FGF10-inducedmorphogenesis
of the endodermal explants (Fig. 2, compare Panels E to F–H). Doses as
Fig. 2. All three TGFβ ligands inhibit FGF10-induced morphogenesis of mesenchyme-free lung endodermal explants. Isolated endodermal explants from E12.5 mouse embryos were
cultured in presence or absence of 10 ng/ml of each of the three TGFβs. Panels A–D show representative explants at time zero. Panels E–H show the same explants after 48 h of
culturing. FGF10 induced endodermal morphogenesis in the absence of TGFβ (Panel E, arrows). Doses as low as 1 ng/ml or as high as 10 ng/ml of TGFβ profoundly inhibited FGF10-
induced morphogenesis (Panels J and K). A dose of 0.1 ng/ml of TGFβ showed partial inhibition (Panel I).
Fig. 3. Generation and validation of Smad4 and TβRII conditional knock-out alleles. Lung
endodermal-speciﬁc inactivation of Smad4 (Panel A) and TβRII (Panel B) via recom-
bination by Nkx2.1-cre was detected by PCR analysis as described in the Materials and
methods. DNA isolated from control and mutant lungs was analyzed using primers that
were previously described (Yang et al., 2002; Chytil et al., 2002). The PCR products and
the identity of the genotypes are as follows: a/b=Smad4ﬂ/ﬂ, a/c=Smad4Δ/Δ, 8w/
LoxP=TβRII ﬂ/ﬂ and 8w/SAr=TβRII Δ/Δ.
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Matrigel cultures (Fig. 2, Panels J to K).
TGFβ inhibition of FGF10-induced endodermal morphogenesis is rescued
by TβRII deﬁciency
To determine themechanisms of TGFβ-induced inhibition of endo-
dermal morphogenesis, we analyzed the cell surface and intracellular
components of the TGFβ pathway using genetically modiﬁed endo-
dermal tissues. At the cell surface, TGFβ ligand binding stabilizes a
complex consisting of type I and type II receptors. The role of type II
receptor, TβRII is pivotal as it mediates the phosphorylation and
activation of SMAD2 and SMAD3,which can then bind to SMAD4, enter
the nucleus and activate or repress target genes. We therefore, ex-
amined the role of SMAD3, SMAD4 and TβRII in the TGFβ inhibition of
FGF10-induced endodermal morphogenesis. For this purpose, lung
endodermal explants were isolated from E12.5 Smad3−/− embryos or
embryos conditionally deleted for Smad4or TβRII. Conditional deletion
of Smad4 [referred to here as Smad4Δ/Δ] or TβRII [TβRIIΔ/Δ] was
achieved by the use of an Nkx2.1-cre/loxP system. Recombination by
Nkx2.1-cre was veriﬁed by PCR genotyping as described previously
for each of the Floxed genes used in this study (Please seeMaterials and
methods and Fig. 3).
Mesenchyme-free lung endodermal explants from Smad3−/−,
Smad4Δ/Δ or TβRIIΔ/Δ embryos were then treated with FGF10 in pre-
sence or absence of TGFβ In presence of FGF10 alone, morphogenesis
of Smad3−/− endoderm was somewhat, but not signiﬁcantly reduced
compared to the wild-type controls (Fig. 4. compare Panels I and K).
Whereas little to no bud formation could be detected in the wild-type
endoderm exposed to a combination of FGF10 plus TGFβ (Fig. 4, Panel
J), those from the Smad3−/− embryos showed deﬁnitive evidence of
morphogenesis (Fig. 4, Panel L). However, deletion of Smad3 did not
completely restore budding to the extent found in the wild-type
endoderm. Similarly, Smad4Δ/Δ endodermal explants branched in the
absence of TGFβ (Fig. 4, PanelM), butwere only partly resistant toTGFβinhibition (Fig. 4, Panel N). Therefore, TGFβ inhibition is only partly
mediated through the activity of SMAD3or SMAD4.We did not deem it
necessary to examine the role of SMAD2, primarily due to the partial
Fig. 4. Analysis of the role of TGFβ pathway components in TGFβ-induced inhibition of endodermal morphogenesis. Endodermal explants from E12.5 wild type, Smad3−/−, Smad4Δ/Δ
and TβRIIΔ/Δ embryos were cultured in presence of 400 ng/ml FGF10, plus or minus 10 ng/ml of TGFβ. Panels A–H show the explants at time zero. After 48 h in FGF10 alone, all
endodermal explants underwent robust morphogenesis (Panels I, K, M and O). Whereas TGFβ had a profound inhibitory impact on wild-type endodermal branching (Panel J),
endoderm from Smad3−/− and Smad4Δ/Δ lungs showed partial resistance to inhibition (Panels L and N). TβRII Δ/Δ endodermwas refractive to TGFβ inhibition (Panel P). Arrows show
the sites of budding.
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interrupt TGFβ signaling by conditional, endodermal-speciﬁc deletion
of TβRII. Mesenchyme-free lung endodremal explants from TβRIIΔ/Δ
E12.5 embryos showed robust endodermal morphogenesis when ex-
posed to FGF10 (Fig. 4, Panel O) and were almost entirely refractive to
the inhibitory effect of TGFβ (Fig. 4, Panel P).
TGFβ1 inhibition of FGF10-induced budding is associated with repression
of Nkx2.1
To ascertain the impact of TGFβ treatment on cell differentiationwe
used immunohistochemistry to examine the distribution of NKX2.1, a
homeodomain transcription factor that is an early marker of lung
endodermal progenitor cell speciﬁcation. Robust expression of NKX2.1
could be detected in endodermal cells explanted in presence of FGF10
alone (Fig. 5, Panel B). Addition of TGFβ for 48 h reduced NKX2.1
protein in endodermal cells (Fig. 5, Panel C). A downstream target of
NKX2.1 in embryonic lung endoderm is SpC, which encodes pulmonary
surfactant protein C. SpC expression in the lung is strictly dependent on
NKX2.1 (Minoo et al., 1999). Therefore, we speculated that repression
of NKX2.1 should also result in reduced or absent SPC in the endo-
dermal explants treated with TGFβ. Using endodermal explants from
SpC-Gfp transgenic embryos,we examined byﬂuorescencemicroscopythe activity of the SpC promoter in response to TGFβ. GFP levels were
readily detected throughout the lung endoderm, explanted inpresence
of FGF10 alone (Fig. 5, Panel E). In explants treated with FGF10, plus
TGFβ, little if any ﬂuorescence could be detected, suggesting that the
SpC promoter activity is inhibited by TGFβ (Fig. 5, Panel F). The
reduced expression of Nkx2.1 and SpC were further veriﬁed by semi-
quantitative PCR analysis (Fig. 7).
Another downstream target of NKX2.1 (Zhu et al., 2004) and a key
mediator of endodermal morphogenesis in the lung is bone morpho-
genetic protein 4 (Weaver et al., 2003). We used a Bmp4LacZ/+ reporter
knock-in mouse line to localize Bmp4-dependent LacZ expression in
the lung endodermal explants. As expected, in FGF10-treated explants,
Bmp4 showed a restricted pattern of expression in the terminal tips of
the budding endoderm (Fig. 5, Panel H). In explants treatedwith TGFβ
inhibition of morphogenesis was accompanied by absence or reduced
levels of Bmp4 (LacZ) gene expression (Fig. 5, Panel I). Thus, TGFβ also
represses Bmp4 gene expression in embryonic endodermal explants.
TGFβ1 inhibits FGF10-induced cell proliferation
TGFβ is known to stimulate apoptosis (Bright et al., 1997) and
inhibit cellular proliferation (Goey et al., 1989). To examine whether
TGFβ inhibition of FGF10-induced endodermal morphogenesis
Fig. 5. TGFβ represses morphogenetic gene expression in embryonic endodermal explants. Immunohistochemistry showed signiﬁcant reduction in NKX2.1 transcription factor in
TGFβ-treated endodermal explants (compare Panel C to A or B). Similarly, TGFβ reduced expression of two NKX2.1 target genes, SpC and Bmp4 as documented by reduced
ﬂuorescence in Spc-Gfp, (compare Panel F to D or E) and reduced LacZ staining in Bmp4LacZ/+ endodermal explants (compare Panel I to G or H). Arrows show positive LacZ staining at
the tip of buds.
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we used the BrdU labeling approach. These analyses showed thatwhen
compared to FGF10 alone, explants treated with FGF10 plus TGFβ had
approximately 25% to 35% decrease in cellular proliferation (Fig. 6,
Panels A–D and H). The endodermal explants were also analyzed for
apoptosis by TUNEL staining. We found no evidence of apoptosis as
assessed by TUNEL in either FGF10 treated explants (Fig. 6, Panel C) or
those treated with FGF10+TGFβ (Fig. 6, Panel F). E11.5 wild-typewhole
lung sectionwas used as positive control (Fig. 6, Inset Panel G). There-
fore, TGFβ does not appear to impact apoptosis.
Pten mediates the effect of TGFβ-induced inhibition of cell proliferation
Semiquantitative PCR analysis of mRNA was conducted for a
number of genes including Nkx2.1, SpC and Pten, a lipid phosphatase
closely associated with regulation of cell proliferation (Andrés-Pons
et al., 2007). The results forNkx2.1 and SpC conﬁrmed the observations
in Fig. 7; SpC mRNA became undetectable, whereas a nearly 74%
reduction was observed in Nkx2.1 mRNA in response to TGFβ treat-
ment. Importantly, the PCR analysis showed increased Pten mRNA in
the endodremal explants treated with TGFβ (Fig. 7). Thus, we hypo-
thesized that the inhibitory activity of TGFβ on endodermal cell
proliferation may be mediated through increased Pten. To test this
hypothesis, we ﬁrst validated the PCR results by precise measurement
of mRNA for Pten and its transcriptional regulator EGR1 (Okamura
et al., 2005; Virolle et al., 2001). Real-time PCR analysis showed a 4-fold
increase in PtenmRNA in endodermal explants treatedwith TGFβ (Fig.
8, Panel A). Treatment with TGFβ also increased Egr1 mRNA level by
nearly 14 fold (Fig. 8, Panel B). To test the functional involvement of
Pten, the response to TGFβ of lung endodermal explants from
conditionally deleted Pten Nkx2.1-cre-driven recombination was
examined (Fig. 9). Deletion of one copy of Pten gene [PtenΔ/+] in theendodermwas sufﬁcient to cause major changes in response to FGF10
alone. In contrast to the control [Ptenﬂox/ﬂox] which showed normal
morphogenesis when treated with FGF10, only marginal budding was
observed in PtenΔ/+ endoderm (Fig. 10, Panel G). This observation sug-
gested that even reduced Pten interferes with normal processes in-
volved in morphogenesis (haploinsufﬁciency) at least in the mesench-
yme-free endodermal explant culture model. Consistent with this
conclusion, homozygous deletion of Pten [PtenΔ/Δ], entirely abrogated
budding altogether (Fig. 10, Panel K). Importantly however, both hete-
rozygous and homozygous deletion of Pten overcame the TGFβ-
induced inhibition of cell proliferation as assessed by size of the
explant and BrdU labeling index measurements (Fig. 11). This ﬁnding
demonstrates that the PTEN/AKT pathwayplays a key role in the TGFβ-
induced inhibition of lung endodermal cell proliferation.
Discussion
The current study examined the role of TGFβ in lung morphogen-
esis in explant culture. Treatment of mouse embryonic lungs had
little discernible effect on the process of branching morphogenesis.
However, morphogenesis of mesenchyme-free lung endodermal
explants in response to FGF10 was profoundly inhibited by
concentrations as low as 1 ng/ml of all three isoforms of recombinant
TGFβ ligands. TGFβ inhibited endodermal morphogenesis concomi-
tant with repression of Nkx2.1 and its downstream targets SpC and
BMP4. Deletion of either Smad3 or Smad4 only partially relieved
the inhibitory effect of TGFβ, whereas conditional deletion of TβRII
completely blocked it. TGFβ inhibited endodermal cell proliferation
in association with increased expression of Pten. Endodermal-speciﬁc
deletion of Pten inhibited morphogenesis in the absence of TGFβ.
Importantly however, PtenΔ/Δ endodermal explants were refractory
to TGFβ-induced inhibition of cell proliferation. Therefore, TGFβ-
Fig. 6. TGFβ represses endodermal cell proliferation. Endodermal explants cultured in presence of FGF10 (400 ng/ml) (Panels A–C) or FGF10 (400 ng/ml))+TGFβ (10 ng/ml) (Panels D–
F) were assayed for cell proliferation by BrdU labeling (Panels A, B, D and E). Panels B and E are high magniﬁcation of Panels A and D (arrows show BrdU positive cells). Panel H shows
quantiﬁcation of the BrdU positive cells (p value of 0.049). TUNEL analysis showed no detectable apoptosis (Panels C and F). Panel G (inset) shows positive control for apoptosis in
whole lung explant culture.
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signaling and likely repression of Nkx2.1, but is not entirely Smad-
dependent. Inhibition of cell proliferation on the other hand, as a
component of TGFβ's inhibitory role on morphogenesis is in large
part due to its impact on the PTEN/AKT pathway.Fig. 7. Analysis of gene expression in endodermal explants treated with TGFβ. RNA
isolated from E12.5 wild-type endodermal explants treated with FGF10 or FGF10+TGFβ
for 2 days was analyzed by semi-quantitative RT-PCR. mRNA for SpC and Bmp4 became
undetectable, whereas Nkx2.1, N-myc and Shh mRNA were reduced. Pten mRNA was
increased.Contrary to previous reports (Zhao et al., 1999a; Serra et al., 1994),
we foundno inhibition of branching by10 or 50ng/ml of TGFβ inwhole
lung explants. Serra et al. (1994) reported TGFβ inhibition at relatively
high doses (30 ng/ml to100 ng/ml). Thus, the observed phenotypemay
simply reﬂect toxic/pathologic consequences of high TGFβ concentra-
tions. The TGFβ concentration used in our studies was the same as that
used by Zhao et al (1999a). Plasminogen activator inhibitor, PAI-1 is
induced by TGFβ in a number of cell types (Liu et al., 1997). The ﬁnding
by Real-time PCR that TGFβ increased PAI-1 mRNA in whole lung ex-
plants, conﬁrmed that the TGFβ in our studies was indeed functional.
Exposure of embryonic lungs in culture to TGFβ expressing adeno-
viruses also had no impact on branching morphogenesis, whereas
injection of viruses into the lumen of the embryonic lungs did (Zhao et
al., 1999b). It is therefore possible that recombinant TGFβ, much like
the TGFβ-adenoviruses does not diffuse adequately through the me-
senchyme to reach the endodermal layer. This is the most likely
explanation for the discrepancy between our ﬁndings and the other
two previous reports. The latter is also consistent with the report by
Zhou et al who found inhibition of lung morphogenesis in transgenic
lungs over-expressing TGFβ speciﬁcally in the lung epithelial layer
(Zhou et al., 1996).
In the current study, we utilized a mesenchyme-free endodermal
explant model to examine the direct impact of TGFβ on isolated
murine lung endoderm. TGFβ inhibited FGF10-induced endodermal
morphogenesis in association with alterations in speciﬁc gene
expression. A notable change occurred in the level of NKX2.1, a
homeodomain transcription factor whose activity is critical for lung
endodermal morphogenesis in vivo (Minoo et al., 1995, 1999; Kimura
et al., 1999). In Nkx2.1−/− embryos, FGF10 is produced by the
Fig. 8. Real-time PCR quantiﬁcation of Pten and Egr1 mRNA in endodermal explants. RNA from endodermal explants treated with FGF10 alone or FGF10+TGFβ, after 2 days in culture
was analyzed for Pten (Panel A) and Egr1 (Panel B) gene expression by Real-time PCR. Both Pten and Egr1 mRNA were increased.
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NKX2.1 may be to interpret and implement mesenchymal FGF10
instructional signaling. In our studies, we found signiﬁcant reduction
in NKX2.1 protein by immunohistochemistry. This ﬁnding was
conﬁrmed by PCR analysis of mRNA (Fig. 7). Furthermore, expression
of a lung-speciﬁc target of NKX2.1, SpC was also profoundly inhibited
by TGFβ (Figs. 5 and 7). The latter occurs either as a consequence of
changes in the level of NKX2.1 and/or indirectly through interactions
between NKX2.1 and Smad3 as we have previously shown in cell
culture for another NKX2.1 target, SpB (Li et al., 2002). Another
downstream target of NKX2.1 in the lung endoderm is Bmp4 (Zhu etFig. 9. Inactivation of mouse Pten gene and generation of PtenΔ/Δ allele. Tissue-speciﬁc
inactivation of the PtenΔ/Δ conditional allele by Nkx2.1-cre transgene was detected by
PCR analysis (Panel A). Primers for recombination analysis (Panel B) were designed as
described by Freeman et al., 2006. The PCR products and the identity of the genotypes
are as follows: P1/P2, upper band in PtenΔ/Δ lungs is the result of mesenchymal DNA
ampliﬁcation. P1/P3 primers amplify only the deleted Pten allele.al., 2004). Bmp4 is thought to be induced by FGF10 and dynamic
interactions between the two signaling pathways may be necessary
for normal endodermal branching (Weaver et al., 2000). Using
endoderm from Bmp4LacZ/+ mouse embryo, we found that treatment
with TGFβ strongly inhibited Bmp4. Inhibition of Bmp4 through over-
expression of Noggin, its cellular inhibitor or a dominant negative
Bmp4 receptor results in abnormal branching morphogenesis (Ebla-
ghie et al., 2006). Other regulators of branchingmorphogenesis whose
expression decreased in the lung endoderm by TGFβwere Shh and N-
Myc (Fig. 8). SHH, the vertebrate homologue of Drosophila HH, which
is highly expressed by embryonic lung endoderm is a major signaling
pathway in lung morphogenesis. SHH is thought to control Fgf10 gene
expression in the lung mesenchyme. Targeted disruption of Shh leads
to arrested endodermal branching in mouse embryos (Pepicelli et al.,
1998). The mechanism by which TGFβ represses Shh remains to be
elucidated.
Many biological effects of TGFβ are ascribed to SMAD-dependent
pathways. In particular, TGFβ inhibition of cell differentiation in
osteoblasts andmuscle progenitor cells ismediated by SMAD3 (Aliston
et al., 1994; Liu et al., 2001). In the lung, although normal embryonic
development is not perturbed in Smad3−/−mice, adult animals develop
an emphysema like condition (Datto et al., 1999; Chen et al., 2005;
Bonniaud et al., 2004). In contrast, absence of Smad3 in mutant mice
attenuates bleomycin-induced pulmonary ﬁbrosis indicating at least a
partial role for SMAD3 (Zhao et al., 2002). In pulmonary adenocarci-
noma cells, SMAD3 and not SMAD2 mediates the TGFβ inhibition of
SpB transcription via interactions with NKX2.1 which reduces the
binding afﬁnity of NKX2.1 for its target DNA elements (Li et al., 2002).
The results of the current study indicate that the role of SMAD3 in
TGFβ-induced inhibition of lung endodermal morphogenesis, at least
in explant culture is limited. Absence of SMAD3 resulted in some
protection from TGFβ-induced inhibition, but did not restore normal
branching. Since another potential pathway is that which is activated
by SMAD2,we opted to abrogate the entire SMAD-dependent pathway
by targeted, conditional deletion of Smad4. Endodermal explants from
Smad4Δ/Δ embryos also exhibited only partial restoration of
Fig. 10. Ptenmediates the effect of TGFβ-induced inhibition of cell proliferation. Endodermal explants from E12.5 PtenΔ/Δ lungs were treated with FGF10 (400 ng/ml) alone or FGF10
(400 ng/ml) + TGFβ (10 ng/ml). Explants at time 0 h are shown in Panels A, B, E, F, I and J. Culturing for 48 h showed robust morphogenesis of wild-type explants in presence of FGF10
alone (Panel C) and profound inhibition in response to TGFβ (Panel D). Compared to wild-type explants, both PtenΔ/ﬂox (Panel G) and PtenΔ/Δ (Panel K) endodermal explants showed
signiﬁcant decrease in FGF10-induced morphogenesis. TGFβ did not inhibit the growth of either PtenΔ/ﬂox or PtenΔ/Δ explants (Panels H and L, respectively). (Arrows & and
arrowheads show sites of budding).
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pathways do not play a major role in TGFβ-induced inhibition of
endodermal morphogenesis.Fig. 11. TGFβ does not inhibit PtenΔ/Δ endodermal cell proliferation. Endodermal
explants were treated with BrdU for 3 h. Immunohistochemistry was used to identify
the BrdU positive cells, which were counted on multiple random ﬁelds. Percentages of
BrdU positive cells in total cells are shown. P values are given above bars that indicate
comparisons between samples.Recent ﬁndings have indicated that certain effects of TGFβ,
including its classical impact on induction of ﬁbronectin as well as
the ability to inhibit cell proliferationmay involve SMAD-independent
pathways (Niculescu-Duvaz et al., 2007; Giehl et al., 2000). Thus, TGFβ
activates other signaling cascades, including ERK, JNK and P38 MAP
kinases. Some of these pathways regulate SMAD activation but others
might induce responses unrelated to transcription (Engel et al., 1999).
In addition, mutated TGFβ type I receptor, defective in SMAD
activation, nevertheless activate p38 MAPK signaling in response to
TGFβ (Yu et al., 2002). Extreme sensitivity of the isolated embryonic
lung endoderm to toxicity from MAPK inhibitors, as an experimental
tool, did not permit investigation of the potential role of this pathway.
Undoubtedly, elucidating the links between TGFβ-MAPK and FGF-
MAPKmay reveal additional mechanisms for TGFβ1 inhibition of FGF-
induced budding morphogenesis in lung development.
Growth inhibitory effects of TGFβhavebeen recognized. This can be
accomplished either by increased apoptosis or decreased cellular pro-
liferation (Yamamura et al., 2000). For example, TGFβ inhibits
proliferation by blocking cyclin and cyclin-dependent kinases (Datto
et al., 1995) or by directly suppressing c-Myc expression (Pietenpol et
al., 1990). Treatment of lung endodermal explants with TGFβ did not
change the incidence of endodermal apoptosis (Fig. 6), but reduced
cellular proliferation by 25 to 35% when compared to untreated tissue
(Fig. 6). Concomitant with this decrease, TGFβ also signiﬁcantly
repressed the expression of N-myc that encodes a basic helix-loop-
helix-leucine zipper (bHLHZ) transcription factor (Serra et al., 1994).
Normal expression ofN-myc is essential for lung development through
its impact on cell proliferation and branching morphogenesis (Moens
et al., 1992, 1993; Sawai et al., 1993; Stanton et al., 1992).
A notable ﬁnding of the current study is the involvement of PTEN, a
phosphatase cancer suppressor, in TGFβ-induced inhibition of lung
endodermal cell proliferation. Direct evidence for the latter was
derived by examining the response of PtenΔ/Δ endodermal explants to
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with combination of FGF10 and TGFβ (Figs. 10 and 11). Initial iden-
tiﬁcation of Ptenwas based on its decreased expression in response to
TGFβ in a human keratinocyte cell line, HaCaT (Li and Sun, 1997). In
contrast to the latter, we found increased Pten and its upstream
transcription factor Egr1 in embryonic lung endoderm, treated with
TGFβ. The reason for this discrepancy remains unknown, but it may
simply reﬂect differences between normal, embryonic tissue used in
the current study, compared to a transformed cell line in the previous
work (Li and Sun,1997). However, this ﬁnding correlates well with the
known function of Pten as a regulator of cell proliferation through the
PTEN/AKT pathway. PTEN antagonizes PI3K, which is activated
downstream of tyrosine kinase receptors, a major growth factor
signaling pathway (For Reviews, Goberdhan and Wilson, 2003; Stiles
et al., 2004). Thus, increased expression of Pten is expected to block
cell proliferation as we have found in endodermal explants treated
with TGFβ. To our knowledge this is the ﬁrst demonstration of the role
of PTEN in TGFβ-induced inhibition of lung endodermal cell
proliferation.
In summary, the TGFβ-induced inhibition of lung endodermal
morphogenesis appears to entail at least two related mechanisms.
First, TGFβ via stimulation of the transcription factor EGR1 and its
target gene, Pten has a profound inhibitory effect on endodermal cell
proliferation. Inhibition of cell proliferation undoubtedly slows, if not
block morphogenesis. In addition, however, TGFβ has a direct impact
on morphoregulatory genes, such as Nkx2.1 and Bmp4, two molecules
that are absolutely required for endodermal morphogenesis. Both of
the latter mechanisms are dependent on intact TβRII-mediated
signaling. The partial role of SMADs in this pathway is a novel ﬁnding
that indicates a key role for alternative, SMAD-independent TGFβ
signaling pathways.
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